Top Markets
#1 Islamic Coin Islamic Coin +151.57%
#2 Black Phoenix Black Phoenix +35.20%
#3 Velvet Velvet +24.01%
#4 Akedo Akedo +19.95%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.32%
#6 Fake World Assets Fake World Assets +16.68%
#7 DoubleZero DoubleZero +13.22%
#8 clBTC clBTC +11.84%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.39%
#10 HOME HOME +10.84%
Coin of the day
Islamic Coin Islamic Coin
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Nabriva Therapeutics plc Nabriva Therapeutics plc

Nabriva Therapeutics plc

NBRV
Classificação em ações #39980
Nabriva Therapeutics plc is a biopharmaceutical company focused on the... Nabriva Therapeutics plc is a biopharmaceutical company focused on the discovery and commercialization of innovative anti-infective medications to combat serious infections. The company's current marketed products include SIVEXTRO, an oxazolidinone-class antibacterial designed for the treatment of acute bacterial skin and skin structure infections (ABSSSI), and XENLETA, a semi-synthetic pleuromutilin antibiotic utilized in managing community-acquired bacterial pneumonia. Beyond its existing offerings, Nabriva is further exploring XENLETA's potential in Phase I clinical trials for a broad spectrum of indications, such as pediatric infections, sexually transmitted infections, cystic fibrosis, ABSSSI, ventilator-associated and hospital-acquired bacterial pneumonia, osteomyelitis, and prosthetic joint infections. Additionally, the firm is developing CONTEPO, an epoxide antibiotic for complicated urinary tract infections, which is also undergoing Phase I clinical evaluation for peri-operative prophylaxis. Originally incorporated in 2005 as Nabriva Therapeutics Forschungs GmbH, the company rebranded to Nabriva Therapeutics plc in 2007 and maintains its corporate headquarters in Dublin, Ireland.
Preço da ação
$0.63
Última sincronização: 2023-08-29
Valor de mercado
$284.20K
Variação (1 dia)
-21.25%
Variação (1 ano)
0.00%
País
IE
Negociar Nabriva Therapeutics plc (NBRV)

Categoria

Healthcare
Histórico de desdobramentos de ações de Nabriva Therapeutics plc (NBRV)
As ações Nabriva Therapeutics plc (símbolo: NBRV) passaram por um total de 0 desdobramentos.
O desdobramento mais recente ocorreu em Aug 14, 2026.
Uma ação NBRV comprada antes de Aug 14, 2026 equivaleria hoje a 0 ações NBRV.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
Não há dados suficientes para as datas fornecidas.
Desdobramentos de ações de empresas semelhantes ou concorrentes
Empresa Número de desdobramentos de ações Multiplicador cumulativo País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE